Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Germany”
- A Study to Test Whether Treatment With BI 770371 in Combination With Pembrolizumab With or Without Cetuximab Helps People With Head and Neck Cancer Compared With Pembrolizumab AloneActive Not Recruiting
Sponsor: Boehringer Ingelheim
Head and Neck Squamous Cell Carcinoma
United States, Australia, Brazil, Bulgaria, France +17 more
Sponsor: Cytokinetics
Heart Failure · Heart Failure With Reduced Ejection Fraction
United States, Canada, China, France, Germany +5 more
- A Study Evaluating the Efficacy and Safety of Crovalimab Versus Eculizumab in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Not Previously Treated With Complement InhibitorsActive Not Recruiting
Sponsor: Hoffmann-La Roche
Paroxysmal Nocturnal Hemoglobinuria
Argentina, Brazil, China, France, Germany +18 more
- A Study of LY4100511 (DC-853) in Adult Participants With Moderate-to-Severe Plaque PsoriasisCompleted
Sponsor: DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company
Plaque Psoriasis
United States, Canada, Czechia, Germany, Hungary +2 more
- Product Surveillance RegistryRecruiting
Sponsor: Medtronic
Cardiac Rhythm Disorders · Urological Disorders · Neurological Disorders · Cardiovascular Disorders
United States, Argentina, Australia, Austria, Belgium +36 more
- A Study of Novel Study Interventions and Combinations in Participants With Colorectal CancerRecruiting
Sponsor: AstraZeneca
Metastatic Colorectal Cancer
United States, Australia, Canada, China, France +7 more
- A Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as Adjuvant Treatment in Patients With HR+/HER2- Early Breast CancerActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Early Breast Cancer
United States, Argentina, Australia, Austria, Belgium +15 more
Sponsor: ResMed
Obstructive Sleep Apnea · Central Sleep Apnea · Mixed Sleep Apnea
Germany
- Enhancing Social Skills in Schizophrenia Spectrum Disorders - Oxytocin as add-on to Psychosocial TreatmentActive Not Recruiting
Sponsor: Central Institute of Mental Health, Mannheim
Schizophrenia Spectrum Disorders (SSD)
Germany
Sponsor: Pfizer
Atopic Dermatitis
United States, China, Germany, Hungary, Japan +3 more
- A Clinical Trial to Investigate Long-term Safety, Tolerability, and Efficacy of Weekly Subcutaneous Doses With TransCon CNP in Children and Adolescents With AchondroplasiaEnrolling By Invitation
Sponsor: Ascendis Pharma Growth Disorders A/S
Achondroplasia
United States, Australia, Austria, Canada, Denmark +7 more
Sponsor: Pfizer
Advanced Non-Small Cell Lung Cancer · Non-Small Cell Lung Cancer · Carcinoma, Non-Small-Cell Lung · Carcinoma, Non-Small-Cell Lung (NSCLC)
United States, Argentina, Australia, Brazil, Canada +15 more
- SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTNActive Not Recruiting
Sponsor: Medtronic Vascular
Hypertension · Vascular Diseases · Cardiovascular Diseases · Chronic Kidney Diseases
United States, Australia, Belgium, France, Germany +6 more
- Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPCActive Not Recruiting
Sponsor: Pfizer
mCRPC
United States, Argentina, Australia, Belgium, Brazil +21 more
- Iberdomide vs. Iberdomide Plus Isatuximab Maintenance Therapy Post ASCT in Newly Diagnosed Multiple MyelomaActive Not Recruiting
Sponsor: University of Heidelberg Medical Center
Multiple Myeloma
Austria, Germany
Sponsor: Azafaros B.V.
Niemann-Pick Type C Disease
United States, Argentina, Australia, Brazil, Canada +10 more
Sponsor: Almirall, S.A.
Nummular Eczema
Germany
- Gyrate Atrophy Ocular and Systemic StudyActive Not Recruiting
Sponsor: Jaeb Center for Health Research
Gyrate Atrophy · Gyrata of Choroid and Retina; Atrophy · Ornithine-δ-aminotransferase · OAT
United States, Brazil, Canada, Finland, France +3 more
- A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.Active Not Recruiting
Sponsor: Sanofi
Relapsing Multiple Sclerosis · Secondary Progressive Multiple Sclerosis · Progressive Relapsing Multiple Sclerosis
United States, Argentina, Australia, Austria, Belgium +42 more
Sponsor: University of Leipzig
Enterostomy
Austria, Germany, Netherlands
Sponsor: Tubulis GmbH
Ovarian Cancer · Non-small Cell Lung Cancer
United States, Belgium, Germany, Romania, Spain +2 more
Sponsor: Bristol-Myers Squibb
Non-small Cell Lung Cancer
United States, Argentina, Australia, Austria, Belgium +26 more
Sponsor: Pfizer
Intestinal Neoplasms · Gastrointestinal Neoplasms · Digestive System Neoplasms · Neoplasms by Site
United States, Argentina, Australia, Belgium, Brazil +12 more
Sponsor: Generate Biomedicines
Severe Asthma
United States, Bulgaria, Germany, Hungary, Latvia +4 more
Sponsor: Hoffmann-La Roche
Progressive Multiple Sclerosis
Australia, France, Germany, Hungary, Italy +6 more